Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Investigating the effects of Griffonia simplicifolia on pain and sensitization in healthy volunteers

Official title: The Effect of Griffonia Simplicifolia on Pain Intensity, Central and Peripheral Sensitization, Painmodulation in Healthy Volunteers - A Randomized, Double-blinded, Placebo-controlled, Cross-over Study

Run by Medical University of Graz · NCT06893822 · Data updated 2026-11-12

This study is testing if a natural supplement called Griffonia simplicifolia can help reduce pain and sensitivity in healthy people.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment20 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz)
StatusRecruiting
StartedSeptember 12, 2025
Main results expectedDecember 20, 2025
Study endsDecember 20, 2025
Registry record updatedJune 17, 2025
Trial IDNCT06893822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy volunteers without chronic pain or significant medical conditions.

Probably not a fit

Patients with chronic pain, neurological disorders, or those taking certain medications like antidepressants may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study utilizes a randomized, placebo-controlled cross-over design to evaluate the effects of Griffonia simplicifolia, which contains the serotonin precursor 5-hydroxytryptophan (5-HTP), on pain intensity and sensitization mechanisms in healthy individuals. The study aims to explore how 5-HTP influences both peripheral and central sensitization, as well as descending inhibitory pathways, using Quantitative Sensory Testing (QST). By examining these effects, the research seeks to provide insights into the analgesic efficacy of 5-HTP and its potential applications in chronic pain management.

Why it matters

Potential benefit: If successful, this study could lead to new insights into the treatment of chronic pain conditions through the modulation of serotonin levels.

How similar studies have gone: Previous studies have shown some efficacy of 5-HTP in chronic pain conditions, but this specific approach in a human experimental pain model is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Exclusion Criteria:

* pregnancy or breastfeeding.
* renal or hepatic insufficiency
* neurological/dermatological/cardiovascular diseases
* chronic pain and/or use of analgesics
* intake of antidepressants
* intake of MAO inhibitors
* intake of sleep medication
* intake of St. John's wort
* allergy to Griffonia simplicifolia

Where it's running

  • Medical University of Graz
    Graz, Austria
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.